TALKS AND TOPICS COVERED
Overview: terminology; impurity classes; regulatory aspects in drug substance and drug product
Dr. Helmut Buschmann, RD&C
Impurities in excipients
Dr. Helmut Buschmann, RD&C
Polymorphs as impurities: analysis and regulatory aspects
Dr. Jordi Cerón, CRYSFORMA/ ICIQ
http://www.crysforma.com/
Statistical evaluation of stability data according to the ICH Q1E guideline – Shelf-life and Out of Specification data
Dr. Andrea Wolkerstorfer, RD&C
Genotoxic impurities: regulatory background and risk assessment from a regulatory perspective
Dr. Norbert Handler, RD&C
In Silico tools and methods for toxicological assessment of impurities
Dr. Andrea Wolkerstorfer, RD&C
Elemental impurities according to the guideline
Dr. Norbert Handler, RD&C
Control of impurities: The Quality by Design approach
Dr. Fernando Bravo CSOL/ ICIQ
http://www.catalytic-solutions.com/